Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8712 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8598 |
High Similarity |
NPD2801 |
Approved |
0.8554 |
High Similarity |
NPD3749 |
Approved |
0.8494 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8452 |
Intermediate Similarity |
NPD5494 |
Approved |
0.843 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8424 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8421 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8385 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8383 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8373 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8286 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8282 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8266 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8263 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.825 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8225 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8198 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8176 |
Intermediate Similarity |
NPD919 |
Approved |
0.8155 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.815 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.815 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.815 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8144 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8136 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8121 |
Intermediate Similarity |
NPD920 |
Approved |
0.811 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8107 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8081 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8046 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8023 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7977 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7976 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7966 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7953 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.795 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7927 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7917 |
Intermediate Similarity |
NPD3226 |
Approved |
0.791 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7895 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7879 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7869 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7865 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7853 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7831 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7821 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7803 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7791 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7765 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7758 |
Intermediate Similarity |
NPD3750 |
Approved |
0.775 |
Intermediate Similarity |
NPD943 |
Approved |
0.7744 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7702 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7697 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7683 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7669 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7669 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7637 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7622 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7611 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7594 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7581 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7576 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7561 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7546 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7545 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7528 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7528 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7527 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7472 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7459 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7438 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.743 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7418 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7384 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7374 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7371 |
Intermediate Similarity |
NPD37 |
Approved |
0.7363 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7363 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7349 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7345 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7345 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7341 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7337 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7337 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7312 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7312 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7305 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7305 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7301 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7262 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7258 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7238 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7231 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7214 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7214 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7212 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7202 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7202 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7202 |
Intermediate Similarity |
NPD5405 |
Approved |
0.72 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7195 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7193 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7169 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7168 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7125 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7112 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7105 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7091 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7079 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7079 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7077 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7072 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.703 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7022 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7011 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.6995 |
Remote Similarity |
NPD7874 |
Approved |
0.6995 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD411 |
Approved |
0.6988 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6984 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6981 |
Remote Similarity |
NPD9268 |
Approved |
0.697 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6957 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6951 |
Remote Similarity |
NPD2798 |
Approved |
0.695 |
Remote Similarity |
NPD7697 |
Approved |
0.695 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.695 |
Remote Similarity |
NPD7698 |
Approved |
0.6944 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6941 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6936 |
Remote Similarity |
NPD7003 |
Approved |
0.6931 |
Remote Similarity |
NPD7240 |
Approved |
0.6928 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.691 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6906 |
Remote Similarity |
NPD4288 |
Approved |
0.6906 |
Remote Similarity |
NPD5353 |
Approved |
0.6898 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6897 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.689 |
Remote Similarity |
NPD3266 |
Approved |
0.689 |
Remote Similarity |
NPD3267 |
Approved |
0.689 |
Remote Similarity |
NPD1470 |
Approved |
0.689 |
Remote Similarity |
NPD1164 |
Approved |
0.6888 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6888 |
Remote Similarity |
NPD6535 |
Approved |
0.6888 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6888 |
Remote Similarity |
NPD6534 |
Approved |
0.6882 |
Remote Similarity |
NPD2403 |
Approved |
0.6871 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6864
|
Remote Similarity |
NPD5124 |
Phase 1 |